Milosh serves as Chief Financial Officer at RIS Rx, with direct responsibility for financial performance and strategic planning. He has held senior finance and accounting leadership roles in several scaled operating environments, including Alteryx and Avalara. Milosh holds a BBA in Accounting from California State University, Fullerton.
Learn why the world's top pharmaceutical companies trust RIS Rx to protect their patients and improve GTN.
RIS Rx is pioneering real-time GTN Revenue Protection for the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patients at the right time.